{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:32:06Z","timestamp":1788867126726,"version":"build-2803163510"},"reference-count":73,"publisher":"American Medical Association (AMA)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,6,22]]},"DOI":"10.1001\/jama.2021.7872","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T11:39:08Z","timestamp":1621424348000},"page":"2466","source":"Crossref","is-referenced-by-count":113,"title":["Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma"],"prefix":"10.1001","volume":"325","author":[{"given":"Lisa H. Y.","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Saleh","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Whalen-Browne","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"O\u2019Byrne","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"The Research Institute of St Joe\u2019s Hamilton, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"joi210055r2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"key":"joi210055r3","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2019.105859","article-title":"One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting \u00df2-agonist in UK primary care settings.","volume":"162","author":"Buhl","year":"2020","journal-title":"Respir Med"},{"issue":"6","key":"joi210055r4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 Focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.","volume":"146","author":"Cloutier","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"22","key":"joi210055r5","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/jama.2020.21974","article-title":"Managing asthma in adolescents and adults: 2020 asthma guideline update from the National Asthma Education and Prevention Program.","volume":"324","author":"Cloutier","year":"2020","journal-title":"JAMA"},{"issue":"208","key":"joi210055r6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-3-642-23274-9_14","article-title":"Muscarinic receptor antagonists: effects on pulmonary function.","author":"Buels","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"joi210055r7","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jaci.2015.07.046","article-title":"Acute and chronic systemic corticosteroid-related complications in patients with severe asthma.","volume":"136","author":"Lefebvre","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"joi210055r8","doi-asserted-by":"publisher","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"joi210055r9","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2018.12.001","article-title":"Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry.","volume":"12","author":"Canonica","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"4","key":"joi210055r10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.anai.2019.01.018","article-title":"Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: to biologic or not to biologic?","volume":"122","author":"Anderson","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"14","key":"joi210055r12","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jama.2018.2757","article-title":"Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma: a systematic review and meta-analysis.","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"joi210055r13","article-title":"Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA\/ICS) versus LABA\/ICS for adults with asthma.","author":"Kew","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"joi210055r14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/pai.2017.28.issue-6","article-title":"Efficacy and safety of tiotropium in school-age children with moderate-to-severe symptomatic asthma: a systematic review.","volume":"28","author":"Rodrigo","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"7650","key":"joi210055r16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"joi210055r17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"4","key":"joi210055r18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control.","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"1","key":"joi210055r19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control.","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"joi210055r20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"issue":"1","key":"joi210055r21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1034\/j.1399-3003.1999.14a08.x","article-title":"Development and validation of the Mini Asthma Quality of Life Questionnaire.","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"1","key":"joi210055r22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"joi210055r23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire.","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"issue":"5","key":"joi210055r24","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1378\/chest.115.5.1265","article-title":"Validation of a standardized version of the Asthma Quality of Life Questionnaire.","volume":"115","author":"Juniper","year":"1999","journal-title":"Chest"},{"issue":"1","key":"joi210055r25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1034\/j.1399-3003.1999.14a06.x","article-title":"What are minimal important changes for asthma measures in a clinical trial?","volume":"14","author":"Santanello","year":"1999","journal-title":"Eur Respir J"},{"issue":"3","key":"joi210055r26","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jaci.2011.12.986","article-title":"Asthma outcomes: pulmonary physiology.","volume":"129","author":"Tepper","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"joi210055r27","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"joi210055r28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jclinepi.2011.04.015","article-title":"Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.","volume":"65","author":"Akl","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"joi210055r29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses.","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"joi210055r30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. rating the quality of evidence\u2014study limitations (risk of bias).","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"joi210055r31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials.","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika."},{"issue":"3","key":"joi210055r32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/jrsm.v2.3","article-title":"Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability.","volume":"2","author":"Thorlund","year":"2011","journal-title":"Res Synth Methods"},{"issue":"2","key":"joi210055r33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. preparing summary of findings tables and evidence profiles-continuous outcomes.","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"joi210055r34","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. rating the quality of evidence\u2014inconsistency.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"joi210055r35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057132","article-title":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers.","volume":"8","author":"Akl","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"joi210055r36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. rating the quality of evidence\u2014publication bias.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"joi210055r37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. introduction-GRADE evidence profiles and summary of findings tables.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"32","key":"joi210055r38","doi-asserted-by":"publisher","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"issue":"1","key":"joi210055r39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"joi210055r40","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/1536867X1801700402","article-title":"Reconstructing time-to-event data from published Kaplan-Meier curves.","volume":"17","author":"Wei","year":"2017","journal-title":"Stata J"},{"issue":"2","key":"joi210055r41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p values: context, process, and purpose.","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat."},{"key":"joi210055r42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions.","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"10210","key":"joi210055r43","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials.","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet"},{"issue":"13","key":"joi210055r44","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy.","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"joi210055r45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pupt.2012.09.007","article-title":"Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes.","volume":"26","author":"Yoshida","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"joi210055r46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pupt.2016.11.004","article-title":"Effects of tiotropium on lung function in current smokers and never smokers with bronchial asthma.","volume":"42","author":"Yoshida","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"issue":"10","key":"joi210055r47","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/cea.2017.47.issue-10","article-title":"Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.","volume":"47","author":"Jabbal","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"joi210055r48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jaci.2011.04.039","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.","volume":"128","author":"Kerstjens","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"joi210055r49","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaci.2017.01.014","article-title":"A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.","volume":"140","author":"Szefler","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"joi210055r50","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01100-2016","article-title":"A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.","volume":"49","author":"Hamelmann","year":"2017","journal-title":"Eur Respir J"},{"issue":"9","key":"joi210055r51","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/02770903.2018.1514047","article-title":"Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting \u00df2-agonist in for patients with asthma.","volume":"56","author":"Hoshino","year":"2019","journal-title":"J Asthma"},{"issue":"8","key":"joi210055r52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5414\/CP203382","article-title":"Effect of triple therapy in patients with asthma-COPD overlap.","volume":"57","author":"Ishiura","year":"2019","journal-title":"Int J Clin Pharmacol Ther"},{"key":"joi210055r53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/COPD","article-title":"Triple therapy with budesonide\/glycopyrrolate\/ formoterol fumarate improves inspiratory capacity in patients with asthma-chronic obstructive pulmonary disease overlap.","volume":"15","author":"Ishiura","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"joi210055r54","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/cea.v50.10","article-title":"Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics.","volume":"50","author":"Jabbal","year":"2020","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"joi210055r56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12931-020-01349-5","article-title":"Letter to the editor: indacaterol\/glycopyrronium\/mometasone furoate compared with salmeterol\/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.","volume":"21","author":"Watz","year":"2020","journal-title":"Respir Res"},{"issue":"10","key":"joi210055r57","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"joi210055r58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"joi210055r60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium Respimat is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study.","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"joi210055r61","first-page":"19476","article-title":"Assessment of second-line treatments for patients with uncontrolled moderate asthma.","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"joi210055r62","doi-asserted-by":"publisher","first-page":"k4388","DOI":"10.1136\/bmj.k4388","article-title":"Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis.","volume":"363","author":"Zheng","year":"2018","journal-title":"BMJ"},{"key":"joi210055r63","doi-asserted-by":"publisher","first-page":"944","DOI":"10.12659\/MSM.907950","article-title":"Therapeutic effects of a long-acting cholinergic receptor blocker, tiotropium bromide, on asthma.","volume":"24","author":"Zhang","year":"2018","journal-title":"Med Sci Monit"},{"issue":"1","key":"joi210055r64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12890-016-0223-3","article-title":"Efficacy and safety of ipratropium bromide\/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.","volume":"16","author":"Donohue","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"8","key":"joi210055r65","article-title":"Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.","author":"Griffiths","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"joi210055r66","article-title":"Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.","volume":"1","author":"Kirkland","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"joi210055r67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.rmed.2016.07.017","article-title":"Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics.","volume":"118","author":"Blais","year":"2016","journal-title":"Respir Med"},{"issue":"4 Pt 1","key":"joi210055r68","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1164\/ajrccm.152.4.7551366","article-title":"Regular formoterol treatment in mild asthma: effect on bronchial responsiveness during and after treatment.","volume":"152","author":"Yates","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"joi210055r70","first-page":"2301","article-title":"Managing asthma in adolescents and adults: 2020 asthma guideline update from the National Asthma Education and Prevention Program.","volume":"324","author":"Cloutier","year":"2020"},{"issue":"14","key":"joi210055r71","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting \u00df-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis.","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"key":"joi210055r72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13223-017-0190-0","article-title":"Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations.","volume":"13","author":"Aziz-Ur-Rehman","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"9347","key":"joi210055r73","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"joi210055r1","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2020 update. Accessed December 16, 2020. https:\/\/ginasthma.org"},{"key":"joi210055r11","unstructured":"National Heart, Lung, and Blood Institute. Needs assessment report for potential update of the Expert Panel Report-3(2007): guidelines for the diagnosis and management of asthma, April 2014. Accessed December 16, 2020.? https:\/\/www.nhlbi.nih.gov\/sites\/default\/files\/media\/docs\/NHLBAC-Asthma-WG-Report-2-2015.pdf"},{"key":"joi210055r15","unstructured":"Higgins? J, Thomas? J, eds . Cochrane Handbook for Systematic Reviews of Interventions Version 6.2, 2021. Accessed April, 25, 2021.? http:\/\/www.training.cochrane.org\/handbook"},{"key":"joi210055r55","unstructured":"Chiesi Farmaceutici. A multicentre, randomised, double-blind, active-controlled, 3-way cross-over study to evaluate the efficacy and safety of a free combination of 3 doses of CHF 5259 (glycopyrrolate) plus Foster 100\/6\u00b5g (fixed combination of beclomethasone dipropionate plus formoterol) in a metered dose inhaler for the treatment of patients with uncontrolled asthma under medium doses of inhaled corticosteroids plus long-acting \u00df2-agonists. EudraCT number: 2013-003043-36. Accessed December 16, 2020.? https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2013-003043-36\/results"},{"key":"joi210055r59","unstructured":"Pearl Therapeutics? Efficacy and safety of PT001 to placebo and open-label Spiriva Respimat in subjects with persistant asthma. August 12, 2020. Accessed December, 16, 2020.? https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03358147"},{"key":"joi210055r69","unstructured":"Institute for Clinical and Economic Review. Biologic Therapies for Treatment of Asthma Associated With Type 2 Inflammation: Effectiveness, Value, and Value-Based Price Benchmarks. November 13, 2018. Accessed December 16, 2020. https:\/\/icer.org\/wp-content\/uploads\/2020\/10\/Asthma-Revised-Report-FOR-PUBLICATION-11.13.2018.pdf"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2780374\/jama_kim_2021_oi_210055_1624316942.63807.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T12:04:34Z","timestamp":1624363474000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2780374"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":73,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021,6,22]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.7872","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,22]]}}}